Selected research
Industry Research
Phosphate Buffered Saline (PBS) Tablet Industry Research Report 2026
Market perspective
The global Phosphate Buffered Saline (PBS) Tablet market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Phosphate Buffered Saline (PBS) Tablet market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Phosphate Buffered Saline (PBS) Tablet market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Phosphate Buffered Saline (PBS) Tablet market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Phosphate Buffered Saline (PBS) Tablet include Merck, Valiant, Tocris Bioscience, Thermo Fisher, Takara Bio, Spectrum Chemical, R-Biopharm AG, R&D Systems and Novus Biologicals, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Phosphate Buffered Saline (PBS) Tablet market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Phosphate Buffered Saline (PBS) Tablet.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Phosphate Buffered Saline (PBS) Tablet Market by Company
Merck
Valiant
Tocris Bioscience
Thermo Fisher
Takara Bio
Spectrum Chemical
R-Biopharm AG
R&D Systems
Novus Biologicals
MyBioSource
Medicago AB
Bio Basic
Phosphate Buffered Saline (PBS) Tablet Segment by Type
Soluble in 500ML Water
Soluble in 200ML Water
Soluble in 100ML Water
Others
Phosphate Buffered Saline (PBS) Tablet Segment by Application
University Laboratory
Business Research Institute
Others
Phosphate Buffered Saline (PBS) Tablet Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Phosphate Buffered Saline (PBS) Tablet market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Phosphate Buffered Saline (PBS) Tablet and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Phosphate Buffered Saline (PBS) Tablet.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Phosphate Buffered Saline (PBS) Tablet companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Soluble in 500ML Water
- Soluble in 200ML Water
- Soluble in 100ML Water
- Others
Applications
- University Laboratory
- Business Research Institute
- Others
Companies covered
- Merck
- Valiant
- Tocris Bioscience
- Thermo Fisher
- Takara Bio
- Spectrum Chemical
- R-Biopharm AG
- R&D Systems
- Novus Biologicals
- MyBioSource
- Medicago AB
- Bio Basic
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Phosphate Buffered Saline (PBS) Tablet by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Soluble in 500ML Water
- 2.2.3 Soluble in 200ML Water
- 2.2.4 Soluble in 100ML Water
- 2.2.5 Others
- 2.3 Phosphate Buffered Saline (PBS) Tablet by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 University Laboratory
- 2.3.3 Business Research Institute
- 2.3.4 Others
- 2.4 Assumptions and Limitations
3 Phosphate Buffered Saline (PBS) Tablet Breakdown Data by Type
- 3.1 Global Phosphate Buffered Saline (PBS) Tablet Historic Market Size by Type (2021-2026)
- 3.2 Global Phosphate Buffered Saline (PBS) Tablet Forecasted Market Size by Type (2027-2032)
4 Phosphate Buffered Saline (PBS) Tablet Breakdown Data by Application
- 4.1 Global Phosphate Buffered Saline (PBS) Tablet Historic Market Size by Application (2021-2026)
- 4.2 Global Phosphate Buffered Saline (PBS) Tablet Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Phosphate Buffered Saline (PBS) Tablet Market Perspective (2021-2032)
- 5.2 Global Phosphate Buffered Saline (PBS) Tablet Growth Trends by Region
- 5.2.1 Global Phosphate Buffered Saline (PBS) Tablet Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Phosphate Buffered Saline (PBS) Tablet Historic Market Size by Region (2021-2026)
- 5.2.3 Phosphate Buffered Saline (PBS) Tablet Forecasted Market Size by Region (2027-2032)
- 5.3 Phosphate Buffered Saline (PBS) Tablet Market Dynamics
- 5.3.1 Phosphate Buffered Saline (PBS) Tablet Industry Trends
- 5.3.2 Phosphate Buffered Saline (PBS) Tablet Market Drivers
- 5.3.3 Phosphate Buffered Saline (PBS) Tablet Market Challenges
- 5.3.4 Phosphate Buffered Saline (PBS) Tablet Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Phosphate Buffered Saline (PBS) Tablet Players by Revenue
- 6.1.1 Global Top Phosphate Buffered Saline (PBS) Tablet Players by Revenue (2021-2026)
- 6.1.2 Global Phosphate Buffered Saline (PBS) Tablet Revenue Market Share by Players (2021-2026)
- 6.2 Global Phosphate Buffered Saline (PBS) Tablet Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Phosphate Buffered Saline (PBS) Tablet Head Office and Area Served
- 6.4 Global Phosphate Buffered Saline (PBS) Tablet Players, Product Type & Application
- 6.5 Global Phosphate Buffered Saline (PBS) Tablet Manufacturers Established Date
- 6.6 Global Phosphate Buffered Saline (PBS) Tablet Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Phosphate Buffered Saline (PBS) Tablet Market Size (2021-2032)
- 7.2 North America Phosphate Buffered Saline (PBS) Tablet Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Phosphate Buffered Saline (PBS) Tablet Market Size by Country (2021-2026)
- 7.4 North America Phosphate Buffered Saline (PBS) Tablet Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Phosphate Buffered Saline (PBS) Tablet Market Size (2021-2032)
- 8.2 Europe Phosphate Buffered Saline (PBS) Tablet Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Phosphate Buffered Saline (PBS) Tablet Market Size by Country (2021-2026)
- 8.4 Europe Phosphate Buffered Saline (PBS) Tablet Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Phosphate Buffered Saline (PBS) Tablet Market Size (2021-2032)
- 9.2 Asia-Pacific Phosphate Buffered Saline (PBS) Tablet Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Phosphate Buffered Saline (PBS) Tablet Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Phosphate Buffered Saline (PBS) Tablet Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Phosphate Buffered Saline (PBS) Tablet Market Size (2021-2032)
- 10.2 South America Phosphate Buffered Saline (PBS) Tablet Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Phosphate Buffered Saline (PBS) Tablet Market Size by Country (2021-2026)
- 10.4 South America Phosphate Buffered Saline (PBS) Tablet Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Phosphate Buffered Saline (PBS) Tablet Market Size (2021-2032)
- 11.2 Middle East & Africa Phosphate Buffered Saline (PBS) Tablet Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Phosphate Buffered Saline (PBS) Tablet Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Phosphate Buffered Saline (PBS) Tablet Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Merck
- 12.1.1 Merck Company Information
- 12.1.2 Merck Business Overview
- 12.1.3 Merck Revenue in Phosphate Buffered Saline (PBS) Tablet Business (2021-2026)
- 12.1.4 Merck Phosphate Buffered Saline (PBS) Tablet Product Portfolio
- 12.1.5 Merck Recent Developments
- 12.2 Valiant
- 12.2.1 Valiant Company Information
- 12.2.2 Valiant Business Overview
- 12.2.3 Valiant Revenue in Phosphate Buffered Saline (PBS) Tablet Business (2021-2026)
- 12.2.4 Valiant Phosphate Buffered Saline (PBS) Tablet Product Portfolio
- 12.2.5 Valiant Recent Developments
- 12.3 Tocris Bioscience
- 12.3.1 Tocris Bioscience Company Information
- 12.3.2 Tocris Bioscience Business Overview
- 12.3.3 Tocris Bioscience Revenue in Phosphate Buffered Saline (PBS) Tablet Business (2021-2026)
- 12.3.4 Tocris Bioscience Phosphate Buffered Saline (PBS) Tablet Product Portfolio
- 12.3.5 Tocris Bioscience Recent Developments
- 12.4 Thermo Fisher
- 12.4.1 Thermo Fisher Company Information
- 12.4.2 Thermo Fisher Business Overview
- 12.4.3 Thermo Fisher Revenue in Phosphate Buffered Saline (PBS) Tablet Business (2021-2026)
- 12.4.4 Thermo Fisher Phosphate Buffered Saline (PBS) Tablet Product Portfolio
- 12.4.5 Thermo Fisher Recent Developments
- 12.5 Takara Bio
- 12.5.1 Takara Bio Company Information
- 12.5.2 Takara Bio Business Overview
- 12.5.3 Takara Bio Revenue in Phosphate Buffered Saline (PBS) Tablet Business (2021-2026)
- 12.5.4 Takara Bio Phosphate Buffered Saline (PBS) Tablet Product Portfolio
- 12.5.5 Takara Bio Recent Developments
- 12.6 Spectrum Chemical
- 12.6.1 Spectrum Chemical Company Information
- 12.6.2 Spectrum Chemical Business Overview
- 12.6.3 Spectrum Chemical Revenue in Phosphate Buffered Saline (PBS) Tablet Business (2021-2026)
- 12.6.4 Spectrum Chemical Phosphate Buffered Saline (PBS) Tablet Product Portfolio
- 12.6.5 Spectrum Chemical Recent Developments
- 12.7 R-Biopharm AG
- 12.7.1 R-Biopharm AG Company Information
- 12.7.2 R-Biopharm AG Business Overview
- 12.7.3 R-Biopharm AG Revenue in Phosphate Buffered Saline (PBS) Tablet Business (2021-2026)
- 12.7.4 R-Biopharm AG Phosphate Buffered Saline (PBS) Tablet Product Portfolio
- 12.7.5 R-Biopharm AG Recent Developments
- 12.8 R&D Systems
- 12.8.1 R&D Systems Company Information
- 12.8.2 R&D Systems Business Overview
- 12.8.3 R&D Systems Revenue in Phosphate Buffered Saline (PBS) Tablet Business (2021-2026)
- 12.8.4 R&D Systems Phosphate Buffered Saline (PBS) Tablet Product Portfolio
- 12.8.5 R&D Systems Recent Developments
- 12.9 Novus Biologicals
- 12.9.1 Novus Biologicals Company Information
- 12.9.2 Novus Biologicals Business Overview
- 12.9.3 Novus Biologicals Revenue in Phosphate Buffered Saline (PBS) Tablet Business (2021-2026)
- 12.9.4 Novus Biologicals Phosphate Buffered Saline (PBS) Tablet Product Portfolio
- 12.9.5 Novus Biologicals Recent Developments
- 12.10 MyBioSource
- 12.10.1 MyBioSource Company Information
- 12.10.2 MyBioSource Business Overview
- 12.10.3 MyBioSource Revenue in Phosphate Buffered Saline (PBS) Tablet Business (2021-2026)
- 12.10.4 MyBioSource Phosphate Buffered Saline (PBS) Tablet Product Portfolio
- 12.10.5 MyBioSource Recent Developments
- 12.11 Medicago AB
- 12.11.1 Medicago AB Company Information
- 12.11.2 Medicago AB Business Overview
- 12.11.3 Medicago AB Revenue in Phosphate Buffered Saline (PBS) Tablet Business (2021-2026)
- 12.11.4 Medicago AB Phosphate Buffered Saline (PBS) Tablet Product Portfolio
- 12.11.5 Medicago AB Recent Developments
- 12.12 Bio Basic
- 12.12.1 Bio Basic Company Information
- 12.12.2 Bio Basic Business Overview
- 12.12.3 Bio Basic Revenue in Phosphate Buffered Saline (PBS) Tablet Business (2021-2026)
- 12.12.4 Bio Basic Phosphate Buffered Saline (PBS) Tablet Product Portfolio
- 12.12.5 Bio Basic Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst